/Companies

MedGenome

Bangalore, IN · 6 known investors

Find your way into MedGenome

Sign up to see every warm intro you have to MedGenome

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the MedGenome team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

MedGenome provides genetic and molecular diagnostic testing across areas including reproductive care, rare hereditary conditions, oncology, and infectious diseases, and operates a CAP-accredited multiomics laboratory with high-throughput sequencing and a proprietary analytics platform. It serves clinicians, hospitals, and pharma partners primarily across India and South Asia.

Investors · 6

Also in the syndicate · 1

Maj Investlead

Funding

SEC filings, press & company announcements

$47.5M disclosed across 1 of 3 rounds · 2020–2025

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does MedGenome do?
MedGenome provides genetic and molecular diagnostic testing across areas including reproductive care, rare hereditary conditions, oncology, and infectious diseases, and operates a CAP-accredited multiomics laboratory with high-throughput sequencing and a proprietary analytics platform. It serves clinicians, hospitals, and pharma partners primarily across India and South Asia.
Who are MedGenome's investors?
MedGenome's investors include Novo Holdings, Sofina, ATEL Ventures, Peak XV Partners, LeapFrog Investments.
How much funding has MedGenome raised?
MedGenome has disclosed $47.5M raised across 1 of its 3 known rounds.
Where is MedGenome headquartered?
MedGenome is headquartered in Bangalore, IN.